>>Description of the research protocol "BRU_IMM_FXII/ CHUB-Facteur XII-VDC"

Evaluation de nouveaux marqueurs (FXII et vidéocapillarsocopie) dans l'angioedème type 3.
Status : Ongoing (but closed to recruitment)

Additional details

Indication (or studied pathology) : Immuno-allergologie
Brugmann identifier : BRU_IMM_FXII/ CHUB-Facteur XII-VDC
EudraCT identifier : B077201837844


Involved department : Immuno-allergology
Principal investigator : Michel/Mounia
Sponsor : CHUB
Contact : Clinical Research Unit

>This protocol was approved by the Brugmann (monocentrique) ethics committee.